Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|August 21, 2008
ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenograftsZhe-Yu Hu, Xiao-Feng Zhu, Zhen-Dong Zhong, et al.
Vascular Pharmacology|March 2, 2019
Long non-coding RNA-SRA promotes neointimal hyperplasia and vascular smooth muscle cells proliferation via MEK-ERK-CREB pathwayChan-Juan Zhang, Chan Liu, Yu-Xiang Wang, et al.
Molecular Medicine Reports|March 5, 2015
Apogossypolone induces reactive oxygen species accumulation and controls cell cycle progression in Raji Burkkit's lymphoma cellsZhe-Yu Hu, Fei Xu, Rui Sun, et al.
Frontiers in Genetics|November 16, 2020
Germline <i>PALB2</i> Mutations in Cancers and Its Distinction From Somatic <i>PALB2</i> Mutations in Breast CancersZhe-Yu Hu, Liping Liu, Ning Xie, et al.
Translational Oncology|March 21, 2019
Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast CancerDabo Zhou, Quchang Ouyang, Liping Liu, et al.
Annals of Translational Medicine|November 4, 2022
Artificial intelligence scale-invariant feature transform algorithm-based system to improve the calculation accuracy of Ki-67 index in invasive breast cancer: a multicenter retrospective studyNing Xie, Haoyu Zhou, Li Yu, et al.
Pharmacology|February 28, 2019
Genistein Protects H9c2 Cardiomyocytes against Chemical Hypoxia-Induced Injury via Inhibition of ApoptosisYa-Ning Shi, Xiu-Qin Zhang, Zhe-Yu Hu, et al.
Oncotarget|November 9, 2017
Altered DMN functional connectivity and regional homogeneity in partial epilepsy patients: a seventy cases studyChong-Yu Hu, Xiaoping Gao, Lili Long, et al.
Anti-Cancer Drugs|October 2, 2008
ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cellsJian Sun, Zhi-Ming Li, Zhe-Yu Hu, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|February 12, 2026
Real-world efficacy and prognostic factors of CDK4/6 inhibitors in HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer: a multicenter retrospective study from the Dongting Lake region of ChinaBinliang Liu, Tao Wu, Kaili Lu, et al.
Pageof 4